Dossier · CARG · Dormant
CARG · CarGurus, Inc. · Stock research
Last analysed ·
Current thesis
Post-print re-rate has stalled and faded: $38.98 on 2026-08-07 (0.1% under the $39.03 52-week high) to $36.85 on 2026-08-21, with RSI back to 49.7. Seven desks now carry $39–$44 targets and zero upgrades, two insiders sold into the level, and mid-August Manheim fell 1.2% MoM. No company catalyst until the ~2026-11-04 Q3 print.
Kill line
A weekly close below $35 unwinds the post-print re-rate and returns price to the mid-July range (2026-07-17 close $35.00); a Q3 print at or under the $253.5M guide floor, or a second consecutive sub-$50M repurchase quarter, would confirm the break is fundamental rather than positional.
Pick status
Open commitment catalyst in 13dscored if the kill line above fires How this is scored →Latest analysis and events for CARG —
As of 22 August 2026, the latest FrontierPicks analysis for CarGurus, Inc. (CARG): Post-print re-rate has stalled and faded: $38.98 on 2026-08-07 (0.1% under the $39.03 52-week high) to $36.85 on 2026-08-21, with RSI back to 49.7. Seven desks now carry $39–$44 targets and zero upgrades, two insiders sold into the level, and mid-August Manheim fell 1.2% MoM. No company catalyst until the ~2026-11-04 Q3 print.
Kill line: A weekly close below $35 unwinds the post-print re-rate and returns price to the mid-July range (2026-07-17 close $35.00); a Q3 print at or under the $253.5M guide floor, or a second consecutive sub-$50M repurchase quarter, would confirm the break is fundamental rather than positional.
Next dated event on file: — catalyst in 13d.
t# CARG — CarGurus, Inc.
Current Thesis
The post-print re-rate flagged on 2026-08-09 topped out and has been giving ground since. Price closed 2026-08-07 at $38.98, 0.1% under the 52-week high of $39.03; the 2026-08-21 close was $36.85, 5.6% below that high, with RSI(14) at 49.7. Nothing in the fundamentals broke in between — no guidance revision, no company release. What arrived instead was a second wave of target catch-up (Barclays Overweight $41 on 2026-08-10, Oppenheimer Outperform $44 on 2026-08-12, Citigroup Neutral $39 on 2026-08-14), insider supply into it, and a cooling wholesale used-vehicle print.
The leg being bought is unchanged: a capital-light dealer marketplace growing low-teens with Q2 2026 free cash flow of $87.7M and a share count reduced by more than 30% since December 2022 — per-share compounding on a slow-growth revenue line. What has changed is that the market has now had two weeks with that news and has marked the shares down roughly 5.5% from the post-print close while seven desks carry targets between $39 and $44. Every published target sits above spot and none of them came with a rating change.
Bullish and bearish views on CarGurus, Inc.
The model's bull view on CarGurus, Inc. (CARG), in brief: Q2 2026 (2026-08-06): revenue $251.0M, +13% YoY, above the $249.87M consensus; adjusted EPS $0.66 versus $0.61 consensus; adjusted EBITDA $84.7M, +7% YoY; GAAP net income from continuing operations $49.2M. The bear view: The company throttled its own bid before the shares stalled: $29.2M repurchased in Q2 2026 versus $175M in Q1 2026, with cash ending Q2 at $122.1M, down 36% from year-end 2025. Both cases follow in full.
Bull Case
- Q2 2026 (2026-08-06): revenue $251.0M, +13% YoY, above the $249.87M consensus; adjusted EPS $0.66 versus $0.61 consensus; adjusted EBITDA $84.7M, +7% YoY; GAAP net income from continuing operations $49.2M.
- The margin guide moved the right way: FY26 adjusted EBITDA margin is now guided to decline 0.5–1.5pp, replacing the 1.5–2.5pp compression guided at the 2026-05-07 Q1 print. That revision, not the revenue beat, is what produced the target raises.
- Cash conversion held: Q2 operating cash flow $94.6M and non-GAAP free cash flow $87.7M against $84.7M of adjusted EBITDA.
- Dealer base expanded on both axes at Q2: 34,629 paying dealers (+5% YoY), split 26,151 U.S. (+2.6%) and 8,478 international (+11%); consolidated QARSD $6,771, +7% YoY (U.S. $8,134, international $2,568).
- Seven targets published since the print bracket $39–$44: UBS Neutral $40, BTIG Buy $41, RBC Outperform $42, Needham Buy $44 (all 2026-08-07), Barclays Overweight $41 (2026-08-10), Oppenheimer Outperform $44 (2026-08-12), Citigroup Neutral $39 (2026-08-14). The 2026-08-21 close of $36.85 is beneath the lowest of them.
- Simply Wall St's summary of the Q2 disclosures notes the primary revolving credit facility maturity was extended to 2031, alongside the results — balance-sheet optionality for the repurchase program at a time when cash fell to $122.1M.
Bear Case
- The company throttled its own bid before the shares stalled: $29.2M repurchased in Q2 2026 versus $175M in Q1 2026, with cash ending Q2 at $122.1M, down 36% from year-end 2025.
- Insiders sold into the post-print level. TipRanks reported Director Greg Schwartz disposing of 10,000 shares in a single 2026-08-14 transaction valued at $360,700; Investing.com reported CEO Jason Trevisan selling 1,100 Class A shares on 2026-08-07 for $45,166. Both landed inside the two weeks the price has been fading.
- Wholesale used values turned. The Manheim Used Vehicle Value Index read 207.4 at mid-August 2026, down 1.2% against July and flat versus August 2025 — Cox Automotive attributes it to a normal late-summer slowdown, but it removes the YoY tailwind that ran through the first half.
- Second derivative on revenue still points down: +15% in Q1 2026 → +13% in Q2. FY26 guidance of +10–13% ($997.678M–$1.025B) implies further deceleration in the back half.
- Q3 guidance of $253.5–258.5M has its midpoint under the $257.2M consensus, and the $0.63–0.69 EPS guide has its floor exactly at the $0.63 consensus. The November bar was set at, not below, the street.
- Seven target raises, zero upgrades. Two of the seven desks (UBS, Citigroup) carry the higher number with a Neutral rating attached, which marks a model to market rather than adding a buyer.
- U.S. paying dealers grew 2.6% YoY against 11% internationally; domestic growth increasingly rests on QARSD — price and product mix — on a nearly flat dealer count.
Setup & Price Structure
The narrative is maturing. The narrative is well understood, still working on a three-month view — the shares are up 30.5% over three months — but flow is moderating and the marginal headline is a target revision rather than new information. Dating that: the 52-week high of $39.03 was set into the 2026-08-07 post-print session and has not been retaken through 2026-08-21; the three raises dated 2026-08-10, 08-12 and 08-14 each landed on a lower close than the one before.
Observable structure. The 2026-08-21 close of $36.85 sits 5.6% under the 52-week high. GuruFocus recorded a 3.8% single-day decline to $36.20 on 2026-08-11, and market data for 2026-08-19 shows a $35.73–$36.90 range. That frames a post-print shelf roughly $35.7–$37.0, with the pre-print mid-July reference close of $35.00 (2026-07-17) beneath it. RSI(14) at 49.7 is neutral — the momentum that carried the print has been fully worked off without a break of the shelf.
Crowding and positioning observables, stated as observables:
- Seven sell-side targets clustered $39–$44 in the eight sessions after the print, all with ratings unchanged.
- Two dated insider dispositions inside that window (2026-08-07 CEO, 2026-08-14 director), the larger valued at $360,700.
- No company-level catalyst inside the next 30 days; the Q3 print is roughly ten weeks out.
- The macro read-through (Manheim) rolled over at the mid-August checkpoint after leading the first half.
Catalyst Calendar (next 30 days)
- 2026-09-08 — Cox Automotive releases the full-month August Manheim Used Vehicle Value Index (date stated by Cox). The mid-August checkpoint was 207.4, -1.2% versus July and flat YoY; the full print shows whether the late-summer fade deepened.
- ~2026-09-10 (est.) — Kelley Blue Book new-vehicle average transaction price, August reading. The new-versus-used price spread is the funnel into the used market CarGurus monetizes.
- ~2026-09-15 (est.) — Manheim mid-September checkpoint, the first read on whether September wholesale demand stabilizes after the August dip.
- ~2026-11-04 (est.) — Q3 2026 results. Outside the 30-day window, and the only scheduled event that tests the $253.5–258.5M revenue guide, the $82.0–90.0M adjusted EBITDA guide, and whether the repurchase pace recovers from Q2's $29.2M.
What Would Change Our Mind
The structure that matters is the post-print shelf around $35.7–$37.0 and the mid-July reference close of $35.00 underneath it. Losing that shelf on a weekly close below $35 would unwind the entire post-print re-rate and return price to where it traded before the 2026-08-06 beat, making the margin-guide improvement a two-week event rather than a re-rate. That is the gradeable break.
Secondary conditions that would corroborate a fundamental, rather than positional, deterioration: Q3 revenue printing at or below the $253.5M guide floor; a second consecutive quarter of sub-$50M repurchases disclosed in November with cash below the $122.1M Q2 level; FY adjusted EBITDA margin guidance re-widening toward a 1.5–2.5pp decline. On the other side, the read strengthens if the shares retake $39.03 on a closing high with a rating upgrade — not another target raise — attached, or if the September Manheim prints reverse the -1.2% mid-August move.
The catalyst-decay risk is explicit: if 2026-09-08 and the September readings come and go with the shares still inside the $35.7–$37.0 shelf, the name enters the Q3 print having spent two months going nowhere on rising targets, which is a different setup than the one the August print created.
Correlation Notes
- Direct comparable: Cars.com (CARS) on dealer-marketplace subscription trends; both monetize dealer advertising budgets rather than vehicle transactions.
- Used-vehicle retail and inventory: CarMax (KMX) and Carvana (CVNA) — their gross-profit-per-unit commentary leads dealer advertising spend, and both trade off the same Manheim series.
- Franchise dealer groups (LAD, AN, PAG, ABG): their front-end gross margin is the source of the advertising budget CarGurus bills against.
- Macro: the Manheim Used Vehicle Value Index (207.4 at mid-August 2026) and KBB average transaction prices are the two monthly series that move the demand read; auto-loan rate moves affect used affordability with a lag.
- FX and non-US cycle: international dealers grew 11% YoY at Q2 versus 2.6% domestically, so UK and Canadian auto demand and sterling/CAD translation carry increasing weight in the growth line.
Notes
- Two share classes outstanding; insider dispositions cited here are Class A common stock.
- Results are reported 'from continuing operations' — compare historical revenue like-for-like before using pre-2026 totals.
- The buyback is discretionary and has varied widely quarter to quarter ($175M in Q1 2026, $29.2M in Q2 2026); it is not a committed distribution.
- Demand read-through runs through the Manheim Used Vehicle Value Index and KBB average transaction prices, both monthly releases.
- International dealers (UK, Canada) are the faster-growing cohort at +11% YoY as of Q2 2026, adding FX and non-US cycle exposure.
Related · shared themes
HUM
Humana Inc.
Margin-over-volume Medicare Advantage reset reclaimed its trend: the 2026-08-24 close of $386.61 is 2.0% above the prior session and back clear of the last 50-day value observed ($378.33, 2026-08-12), with RSI(14) at 64.6 from 52.5. Revision flow idle since Bernstein's 08-14 Buy/$425, and the 2027 number now has a venue — a 2026-12-10 investor update — past both the 09-08/10 conference window and the 11-06 print. The narrative is maturing.
RXO
RXO, Inc.
Freight-cycle recovery intact; sell-side has fully caught up into a $20–35 battleground — bears $20 (Goldman 07-16, Susquehanna 07-14), bulls $30–35 (BMO $35 initiation 07-14, Stifel/Truist/Citi $30). Narrative matured from mispriced to consensus; the ~2026-08-05 Q2 print (adj EBITDA guide $27–37M vs $6M Q1) is the binary the whole re-rate discounts.
CNC
Centene Corporation
Margin-repair guide raise of 2026-07-28 stays fully priced: the 2026-08-24 close of $65.65 is 2.7% under the 2026-08-14 close of $67.47 and 4.5% below the $68.72 52-week high, with no analyst target moved since Argus on 2026-08-11. maturing; the next company-controlled datapoint is Q3, now calendared 2026-10-27.
HNGE
Hinge Health, Inc.
Digital-MSK profitability re-rate broke out in May and was pushed into open price discovery by the 2026-06-09 mid-quarter raise (Q2 to $200–202M, +45%; FY26 to $818–824M). But nine sell-side target hikes in two weeks plus accelerating insider selling mark a late, distribution-prone phase, with no company catalyst until the ~2026-08-04 Q2 print.
See also · stocks to watch